Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chk2 activation and phosphorylation-dependent oligomerization.

Xingzhi Xu1, Lyuben M Tsvetkov, David F Stern

  • 1Department of Pathology, School of Medicine, Yale University, New Haven, Connecticut 06510, USA.

Molecular and Cellular Biology
|May 25, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cerebrospinal Fluid in Pediatric Neuro-Oncology: Molecular Diagnosis, Disease Monitoring, and Clinical Translation.

International journal of molecular sciences·2026
Same author

Effect of Polyethylene Glycol Loxenatide Treatment on Body Weight in Patients With Type 2 Diabetes With Different Body Mass Index: A Retrospective Real-World Study.

International journal of endocrinology·2026
Same author

A framework for the exploration of subcellular compartmentalization of RNA-binding proteins.

Nature communications·2026
Same author

S-phase PARylation of microprotein RSMC enhances the function of Sororin in sister chromatid cohesion.

The EMBO journal·2025
Same author

MCM5 UFMylation regulates replication origin firing and fork progression.

The EMBO journal·2025
Same author

S-palmitoylation: An oily modification guardinggenome stability.

DNA repair·2025
Same journal

Transcription Factors in Breast Cancer Oncogenesis and Progression.

Molecular and cellular biology·2026
Same journal

Aberrant Expression of miR-25-3p/EZH2 Is Involved in T Cell Activation in Aplastic Anemia.

Molecular and cellular biology·2026
Same journal

Characterization of the m<sup>6</sup>A Epitranscriptome in Fibroblast Senescence.

Molecular and cellular biology·2026
Same journal

Insights into FACT in Cancers with Targeted Therapeutic Implications.

Molecular and cellular biology·2026
Same journal

Human lncRNA, hLinfRNA7 (IDO1-AS) Regulates Cytokine Expression, Tryptophan Catabolism, and Inflammatory Response in Macrophage.

Molecular and cellular biology·2026
Same journal

mTORC1-Dependent Regulation of the CCL24-CCR3 Axis Controls Granuloma Formation and Maintenance in Sarcoidosis.

Molecular and cellular biology·2026
See all related articles

The tumor suppressor CHK2 kinase requires oligomerization for DNA damage response activation. This process, regulated by phosphorylation and ATM, amplifies cell signaling pathways.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Biochemistry

Background:

  • The CHK2 gene encodes a serine/threonine kinase crucial for DNA damage response.
  • CHK2 possesses an N-terminal SQ/TQ cluster domain (SCD), a forkhead-associated (FHA) domain, and a C-terminal kinase domain.
  • Mutations in SCD or FHA domains disrupt CHK2 checkpoint function.

Purpose of the Study:

  • To investigate the mechanisms regulating CHK2 kinase activity and its role in DNA damage response.
  • To elucidate the role of CHK2 oligomerization in its activation and signal transduction.

Main Methods:

  • In vitro kinase assays using cell-free systems.
  • Site-directed mutagenesis of CHK2 domains (SCD and FHA).
  • In vivo studies of CHK2 oligomerization and kinase activity following DNA damage induction (gamma irradiation).

Related Experiment Videos

Main Results:

  • CHK2 autophosphorylation requires trans-phosphorylation by wortmannin-sensitive kinases (ATM/ATR).
  • Active CHK2 phosphorylates both SQ/TQ and non-SQ/TQ sites within its SCD.
  • Mutations in SCD and FHA domains impair CHK2 auto- and trans-kinase activities.
  • CHK2 forms oligomers dependent on FHA and SCD domains, which increase post-DNA damage.
  • CHK2 oligomerization is phosphorylation-dependent, requires ATM for gamma-irradiation-induced oligomerization, and can occur without other proteins.
  • CHK2 can cross-phosphorylate within oligomeric complexes, and induced oligomerization augments kinase activity.

Conclusions:

  • CHK2 oligomerization is a critical regulatory mechanism for its activation and signal amplification in DNA damage checkpoint pathways.
  • Phosphorylation-dependent oligomerization of CHK2 is essential for effective DNA damage response transduction.